Prophylaxis against fungal peritonitis in CAPD a single center experience with low-dose fluconazole

Mayoor V. Prabhu, Sreepada V. Subhramanyam, Sridhar Gandhe, Sinoj K. Antony, K. Shivanand Nayak

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Backgroundaims: Fungal peritonitis (FP) significantly alters the outcome of patients on peritoneal dialysis (PD). Exposure to antibiotics is a risk factor for subsequent FP. Antifungal prophylaxis has been tried, with varying success, to prevent the occurrence of antibiotic-related fungal peritonitis (AR-FP). We aimed to evaluate the effect of prophylaxis with a low dose of fluconazole, in preventing AR-FP. Methods: In this retrospective review, we examined the incidence of FP in a cohort of 115 patients, who had received antibiotics for bacterial peritonitis and received a co-prescription of fluconazole, 50 mgday for the duration of antibiotic therapy. The incidence of bacterial peritonitis and FP for up to 3 months after antibiotic therapy was noted. Results: One hundred and fifteen patients were followed up over a 6-year period, for 2549 patient-months. We observed 82 episodes of bacterial peritonitis and a total of 137 antibiotic prescriptions. The peritonitis rate was 1 episode per 31.08 patient-months (1 per 2.58 patient-year, 0.38 episodes every patient-year). We had six episodes of FP. There were no episodes of AR-FP. Conclusion: We observed very low rates of both bacterial peritonitis and FP, and prophylaxis with low-dose fluconazole seemed to confer protection against AR-FP. We did not encounter any adverse effects with its use.

Original languageEnglish
Pages (from-to)802-805
Number of pages4
JournalRenal Failure
Volume32
Issue number7
DOIs
Publication statusPublished - 01-08-2010

Fingerprint

Continuous Ambulatory Peritoneal Dialysis
Fluconazole
Peritonitis
Anti-Bacterial Agents
Prescriptions
Incidence
Peritoneal Dialysis

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine
  • Nephrology

Cite this

Prabhu, Mayoor V. ; Subhramanyam, Sreepada V. ; Gandhe, Sridhar ; Antony, Sinoj K. ; Nayak, K. Shivanand. / Prophylaxis against fungal peritonitis in CAPD a single center experience with low-dose fluconazole. In: Renal Failure. 2010 ; Vol. 32, No. 7. pp. 802-805.
@article{ba676d158d2a481082b20527fa87e861,
title = "Prophylaxis against fungal peritonitis in CAPD a single center experience with low-dose fluconazole",
abstract = "Backgroundaims: Fungal peritonitis (FP) significantly alters the outcome of patients on peritoneal dialysis (PD). Exposure to antibiotics is a risk factor for subsequent FP. Antifungal prophylaxis has been tried, with varying success, to prevent the occurrence of antibiotic-related fungal peritonitis (AR-FP). We aimed to evaluate the effect of prophylaxis with a low dose of fluconazole, in preventing AR-FP. Methods: In this retrospective review, we examined the incidence of FP in a cohort of 115 patients, who had received antibiotics for bacterial peritonitis and received a co-prescription of fluconazole, 50 mgday for the duration of antibiotic therapy. The incidence of bacterial peritonitis and FP for up to 3 months after antibiotic therapy was noted. Results: One hundred and fifteen patients were followed up over a 6-year period, for 2549 patient-months. We observed 82 episodes of bacterial peritonitis and a total of 137 antibiotic prescriptions. The peritonitis rate was 1 episode per 31.08 patient-months (1 per 2.58 patient-year, 0.38 episodes every patient-year). We had six episodes of FP. There were no episodes of AR-FP. Conclusion: We observed very low rates of both bacterial peritonitis and FP, and prophylaxis with low-dose fluconazole seemed to confer protection against AR-FP. We did not encounter any adverse effects with its use.",
author = "Prabhu, {Mayoor V.} and Subhramanyam, {Sreepada V.} and Sridhar Gandhe and Antony, {Sinoj K.} and Nayak, {K. Shivanand}",
year = "2010",
month = "8",
day = "1",
doi = "10.3109/0886022X.2010.494797",
language = "English",
volume = "32",
pages = "802--805",
journal = "Renal Failure",
issn = "0886-022X",
publisher = "Informa Healthcare",
number = "7",

}

Prophylaxis against fungal peritonitis in CAPD a single center experience with low-dose fluconazole. / Prabhu, Mayoor V.; Subhramanyam, Sreepada V.; Gandhe, Sridhar; Antony, Sinoj K.; Nayak, K. Shivanand.

In: Renal Failure, Vol. 32, No. 7, 01.08.2010, p. 802-805.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prophylaxis against fungal peritonitis in CAPD a single center experience with low-dose fluconazole

AU - Prabhu, Mayoor V.

AU - Subhramanyam, Sreepada V.

AU - Gandhe, Sridhar

AU - Antony, Sinoj K.

AU - Nayak, K. Shivanand

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Backgroundaims: Fungal peritonitis (FP) significantly alters the outcome of patients on peritoneal dialysis (PD). Exposure to antibiotics is a risk factor for subsequent FP. Antifungal prophylaxis has been tried, with varying success, to prevent the occurrence of antibiotic-related fungal peritonitis (AR-FP). We aimed to evaluate the effect of prophylaxis with a low dose of fluconazole, in preventing AR-FP. Methods: In this retrospective review, we examined the incidence of FP in a cohort of 115 patients, who had received antibiotics for bacterial peritonitis and received a co-prescription of fluconazole, 50 mgday for the duration of antibiotic therapy. The incidence of bacterial peritonitis and FP for up to 3 months after antibiotic therapy was noted. Results: One hundred and fifteen patients were followed up over a 6-year period, for 2549 patient-months. We observed 82 episodes of bacterial peritonitis and a total of 137 antibiotic prescriptions. The peritonitis rate was 1 episode per 31.08 patient-months (1 per 2.58 patient-year, 0.38 episodes every patient-year). We had six episodes of FP. There were no episodes of AR-FP. Conclusion: We observed very low rates of both bacterial peritonitis and FP, and prophylaxis with low-dose fluconazole seemed to confer protection against AR-FP. We did not encounter any adverse effects with its use.

AB - Backgroundaims: Fungal peritonitis (FP) significantly alters the outcome of patients on peritoneal dialysis (PD). Exposure to antibiotics is a risk factor for subsequent FP. Antifungal prophylaxis has been tried, with varying success, to prevent the occurrence of antibiotic-related fungal peritonitis (AR-FP). We aimed to evaluate the effect of prophylaxis with a low dose of fluconazole, in preventing AR-FP. Methods: In this retrospective review, we examined the incidence of FP in a cohort of 115 patients, who had received antibiotics for bacterial peritonitis and received a co-prescription of fluconazole, 50 mgday for the duration of antibiotic therapy. The incidence of bacterial peritonitis and FP for up to 3 months after antibiotic therapy was noted. Results: One hundred and fifteen patients were followed up over a 6-year period, for 2549 patient-months. We observed 82 episodes of bacterial peritonitis and a total of 137 antibiotic prescriptions. The peritonitis rate was 1 episode per 31.08 patient-months (1 per 2.58 patient-year, 0.38 episodes every patient-year). We had six episodes of FP. There were no episodes of AR-FP. Conclusion: We observed very low rates of both bacterial peritonitis and FP, and prophylaxis with low-dose fluconazole seemed to confer protection against AR-FP. We did not encounter any adverse effects with its use.

UR - http://www.scopus.com/inward/record.url?scp=77954878736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954878736&partnerID=8YFLogxK

U2 - 10.3109/0886022X.2010.494797

DO - 10.3109/0886022X.2010.494797

M3 - Article

VL - 32

SP - 802

EP - 805

JO - Renal Failure

JF - Renal Failure

SN - 0886-022X

IS - 7

ER -